P Mercie

Summary

Affiliation: CHU de Bordeaux
Country: France

Publications

  1. pmc Rituximab Efficacy during a Refractory Polyarteritis Nodosa Flare
    Emmanuel Ribeiro
    Service de Medecine Interne, Hôpital Saint André, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
    Case Report Med 2009:738293. 2009
  2. pmc The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: a systematic literature review
    Matteo Vassallo
    Department of Infectious Diseases, L Archet Hospital, University of Nice, Nice, France
    Virol J 9:174. 2012
  3. ncbi request reprint Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients
    P Mercie
    Internal Medicine and Infectious Diseases, University Hospital of Bordeaux, France
    HIV Med 6:380-7. 2005
  4. ncbi request reprint Homocysteine-thiolactone induces caspase-independent vascular endothelial cell death with apoptotic features
    P Mercie
    Laboratoire d Hematologie, Universite Victor Segalen Bordeaux 2, France
    Apoptosis 5:403-11. 2000
  5. ncbi request reprint [Physicopathologic mechanisms and methods of analysis of cellular apoptosis]
    P Mercie
    Laboratoire d Hematologie, équipe d accueil 482, Universite Victor Segalen Bordeaux 2, 146, rue Leo Saignat, 33076 Bordeaux, France
    Rev Med Interne 22:90-6. 2001
  6. ncbi request reprint Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement
    Patrick Mercie
    Service de Medecine Interne, Centre d Information et de Soins de l Immunodéfience Humaine, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
    Ann Med 34:55-63. 2002
  7. ncbi request reprint Dual nucleoside regimens in nonadvanced HIV infection: prospective follow-up of 130 patients, Aquitaine Cohort, 1996 to 1998. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA)
    P Morlat
    Service de Medecine Interne et Maladies Infectieuses, Hôpital Saint André, Centre Hospitalier Universitaire, Bordeaux, France
    J Acquir Immune Defic Syndr 23:255-60. 2000
  8. ncbi request reprint Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002
    F Bonnet
    Department of Internal Medicine and Infectious Diseases, Saint Andre Hospital, Bordeaux University Hospital, Bordeaux, France
    HIV Med 6:198-205. 2005
  9. doi request reprint Causes of death in HIV-infected women: persistent role of AIDS. The 'Mortalité 2000 & 2005' Surveys (ANRS EN19)
    Mojgan Hessamfar-Bonarek
    INSERM, U897, Bordeaux, France
    Int J Epidemiol 39:135-46. 2010
  10. ncbi request reprint [Severe lactic acidosis in HIV-infected patients treated with nucleosidic reverse transcriptase analogs: a report of 9 cases]
    F Bonnet
    Fédération de médecine interne, Maladies Infectieuses et Pathologies Tropicales, Hôpital Saint André, Bordeaux, France
    Rev Med Interne 24:11-6. 2003

Detail Information

Publications38

  1. pmc Rituximab Efficacy during a Refractory Polyarteritis Nodosa Flare
    Emmanuel Ribeiro
    Service de Medecine Interne, Hôpital Saint André, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
    Case Report Med 2009:738293. 2009
    ..On the other hand, therapeutic trials are needed to determine the real efficacy and place of rituximab in the treatment of polyarteritis nodosa...
  2. pmc The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: a systematic literature review
    Matteo Vassallo
    Department of Infectious Diseases, L Archet Hospital, University of Nice, Nice, France
    Virol J 9:174. 2012
    ..Recent observational studies suggest a role for lipopolysaccharide (LPS) as a marker of immune activation in HIV-infected patients, with potential repercussions on the effectiveness of antiretroviral regimens...
  3. ncbi request reprint Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients
    P Mercie
    Internal Medicine and Infectious Diseases, University Hospital of Bordeaux, France
    HIV Med 6:380-7. 2005
    ..In a 12-month follow-up study, we aimed to investigate changes in carotid intima-media thickness (IMT), a surrogate marker of atherosclerosis, and its determinants in HIV-1-infected patients...
  4. ncbi request reprint Homocysteine-thiolactone induces caspase-independent vascular endothelial cell death with apoptotic features
    P Mercie
    Laboratoire d Hematologie, Universite Victor Segalen Bordeaux 2, France
    Apoptosis 5:403-11. 2000
    ..Our goal was to investigate the thiol-derivatives effect on the endothelial cell apoptosis...
  5. ncbi request reprint [Physicopathologic mechanisms and methods of analysis of cellular apoptosis]
    P Mercie
    Laboratoire d Hematologie, équipe d accueil 482, Universite Victor Segalen Bordeaux 2, 146, rue Leo Saignat, 33076 Bordeaux, France
    Rev Med Interne 22:90-6. 2001
    ..A better understanding of the mechanisms of apoptosis and tissue specificity of the caspases make it possible to consider in the future the development of synthetic inhibitors as serious candidates for a therapeutic intervention...
  6. ncbi request reprint Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement
    Patrick Mercie
    Service de Medecine Interne, Centre d Information et de Soins de l Immunodéfience Humaine, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
    Ann Med 34:55-63. 2002
    ..We describe carotid artery intima-media thickness (IMT), a surrogate marker of atherosclerosis, according to HIV status, antiretroviral treatment, lipodystrophy and conventional cardiovascular risk factors...
  7. ncbi request reprint Dual nucleoside regimens in nonadvanced HIV infection: prospective follow-up of 130 patients, Aquitaine Cohort, 1996 to 1998. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA)
    P Morlat
    Service de Medecine Interne et Maladies Infectieuses, Hôpital Saint André, Centre Hospitalier Universitaire, Bordeaux, France
    J Acquir Immune Defic Syndr 23:255-60. 2000
    ....
  8. ncbi request reprint Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002
    F Bonnet
    Department of Internal Medicine and Infectious Diseases, Saint Andre Hospital, Bordeaux University Hospital, Bordeaux, France
    HIV Med 6:198-205. 2005
    ..To determine the factors associated with clinical progression (AIDS events and death) in antiretroviral-naive patients who have begun highly active antiretroviral therapy (HAART)...
  9. doi request reprint Causes of death in HIV-infected women: persistent role of AIDS. The 'Mortalité 2000 & 2005' Surveys (ANRS EN19)
    Mojgan Hessamfar-Bonarek
    INSERM, U897, Bordeaux, France
    Int J Epidemiol 39:135-46. 2010
    ..Little is known about the causes of death in human immunodeficiency virus (HIV)-infected women in the era of combination antiretroviral therapy (ART)...
  10. ncbi request reprint [Severe lactic acidosis in HIV-infected patients treated with nucleosidic reverse transcriptase analogs: a report of 9 cases]
    F Bonnet
    Fédération de médecine interne, Maladies Infectieuses et Pathologies Tropicales, Hôpital Saint André, Bordeaux, France
    Rev Med Interne 24:11-6. 2003
    ..Symptomatic lactic acidosis requiring intensive care is a rare and severe adverse event related to the mitochondrial toxicity of the nucleoside analog reverse transcriptase inhibitors (NRTIs)...
  11. pmc Bacterial pneumonia among HIV-infected patients: decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort, 2000-2007
    Antoine Benard
    INSERM, U897, CIC EC7, Bordeaux, France
    PLoS ONE 5:e8896. 2010
    ..Our objective was to estimate the effect of tobacco smoking withdrawal on the risk of bacterial pneumonia among HIV-infected individuals...
  12. ncbi request reprint Symptomatic bone disorders in HIV-infected patients: incidence in the Aquitaine cohort (1999-2002)
    K Martin
    Bordeaux Regional Pharmacovigilance Center, Pharmacology Department, Victor Segalen University, Centre Hospitalier Universitaire, Bordeaux, France
    HIV Med 5:421-6. 2004
    ..Since the inception of highly active antiretroviral therapy (HAART), mortality among HIV-infected patients has decreased, but this has been accompanied by the appearance of several complications...
  13. pmc Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort
    Linda Wittkop
    INSERM, Unit Epidemiology and Biostatistics, Bordeaux, France
    J Antimicrob Chemother 63:1251-5. 2009
    ..We studied viro-immunological response, pharmacokinetic parameters and genotypic test results in an observational cohort of multiple ARV class-experienced patients starting a raltegravir-based regimen...
  14. ncbi request reprint Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey
    Fabrice Bonnet
    Institut National de la Sante et de la Recherche Medicale INSERM, U593, Bordeaux, France
    Clin Infect Dis 48:633-9. 2009
    ....
  15. ncbi request reprint Prevalence and factors associated with renal impairment in HIV-infected patients, ANRS C03 Aquitaine Cohort, France
    E K Déti
    Institut National de la Santé et de la Recherche Médicale U897, Bordeaux, F 33076, France
    HIV Med 11:308-17. 2010
    ..The aims of the present study were to estimate the prevalence of renal impairment (RI) among HIV-infected adult patients and to investigate the associated factors...
  16. ncbi request reprint Incidence and risk factors of severe hypertriglyceridaemia in the era of highly active antiretroviral therapy: the Aquitaine Cohort, France, 1996-99
    R Thiebaut
    Unité INSERM 330, Institut de Santé Publique, d Epidémiologie et de Développement ISPED, Universite Victor Segalen Bordeaux 2, Bordeaux, France
    HIV Med 2:84-8. 2001
    ..To estimate the incidence of serum hypertriglyceridaemia > 6 mm/L (HTG) and identify associated factors in the era of highly active antiretroviral therapy (HAART)...
  17. ncbi request reprint Pharmacokinetics and resistance mutations affect virologic response to ritonavir/saquinavir-containing regimens
    I Pellegrin
    Department of Virology, Bordeaux University Hospital, Bordeaux, France
    Ther Drug Monit 23:332-40. 2001
    ..The authors showed the complementarity between drug-resistance genotype and individual pharmacokinetics and the potential utility of AUC and Cmax to manage treatment...
  18. doi request reprint Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy
    Olivia Peuchant
    Virology Laboratory, Bordeaux University Hospital, Bordeaux, France
    AIDS 22:1417-23. 2008
    ..We investigated the clinical relevance of the detection of majority and minority-resistant variants in an observational study in antiretroviral therapy naive, recently infected patients...
  19. ncbi request reprint Fibrates or statins and lipid plasma levels in 245 patients treated with highly active antiretroviral therapy. Aquitaine Cohort, France, 1999-2001
    F Bonnet
    Service de Medecine Interne et Maladies Infectieuses, Hôpital Saint André, 1 rue Jean Burguet, 33075 Bordeaux cedex, France
    HIV Med 5:133-9. 2004
    ..To describe the effect and tolerance of lipid-lowering drugs (LLD; fibrates and statins) in patients treated with highly active antiretroviral therapy (HAART)...
  20. ncbi request reprint Successful treatment of lupus with fludarabine
    J F Viallard
    Clinique de Medecine Interne, Hopital Haut Leveque, Pessac, France
    Lupus 8:767-9. 1999
    ..A total of 6 cycles were administered. The evolution was complicated by herpes zoster infection and left pneumococcal pneumonia. At this time of writing (July 1999), the patient is symptom free but is profoundly lymphopenic...
  21. doi request reprint Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort
    Marc Arthur Loko
    INSERM, U593, Bordeaux, France
    Am J Gastroenterol 103:1973-80. 2008
    ..Although an increasing number of noninvasive fibrosis markers are available in HCV-monoinfected patients, data on the performance of these tests in HIV-HCV-coinfected patients are lacking...
  22. ncbi request reprint Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999
    F Bonnet
    Fédération de médecine interne, Maladies Infectieuses et Pathologie Tropicale, Hôpital Saint André Bordeaux, France
    HIV Med 3:195-9. 2002
    ..To describe the causes of death in HIV-infected patients in the era of highly active antiretroviral therapy (HAART)...
  23. ncbi request reprint [Endocarditis due to Pasteurella sp. Two cases]
    F Camou
    Service de Medecine Interne et Maladies Infectieuses, CHU Haut Levêque, Avenue Magellan, 33604 Pessac Cedex, France
    Med Mal Infect 35:556-9. 2005
    ..The total death rate is 40% and can reach 57% of cases in case of immunodepression. The bad prognosis of this infection, justifies an early diagnosis and a rapid and adapted but not yet consensual medicosurgical treatment...
  24. ncbi request reprint [Pulmonary plasmacytoma: about two new cases and review of the literature]
    G Etienne
    Service de médecine interne et maladies tropicales, groupe hospitalier Saint André, 1, rue Jean Burguet, 33075 Bordeaux, France
    Rev Med Interne 25:591-5. 2004
    ..Extramedullary plasmacytoma is an uncommon plasma cell malignancy mainly located to the upper aerodigestive tract. Primary pulmonary plasmacytoma is extremely rare...
  25. ncbi request reprint Yellow fever vaccination of human immunodeficiency virus-infected patients: report of 2 cases
    M C Receveur
    Department of Internal Medicine, Infectious and Tropical Diseases, Hospital Saint André, Bordeaux, France marie catherine
    Clin Infect Dis 31:E7-8. 2000
    ....
  26. doi request reprint [The fate of the abstracts presented to the biannual meetings of the French National Society of Internal Medicine]
    G L Gaundong Mbéthé
    Service de Medecine Interne, Hôpital Saint André, Centre Hospitalier Universitaire de Bordeaux, 1, rue Jean Burguet, 33075 Bordeaux cedex, France
    Rev Med Interne 29:1080-2. 2008
    ..Medical meetings give the opportunity to present oral communications or posters to the attending participants. However, the peer-reviewed publication of a full article allows to reach a wide readership...
  27. ncbi request reprint Hepatitis C virus infection with and without cryoglobulinemia as a case of Churg-Strauss syndrome
    P Mercie
    Clinique de médecine interne et maladies infectieuses, Hopital Haut Leveque, Pessac, France
    J Rheumatol 27:814-7. 2000
    ..These observations suggest that IFN-alpha therapy may be effective against CSS in HCV infected patients with or without cryoglobulinemia...
  28. ncbi request reprint Risk factors for lactic acidosis in HIV-infected patients treated with nucleoside reverse-transcriptase inhibitors: a case-control study
    F Bonnet
    Fédération de médecine interne, Maladies Infectieuses et Pathologies Tropicales, Hôpital Saint André, Bordeaux, France
    Clin Infect Dis 36:1324-8. 2003
    ....
  29. doi request reprint [Macroglobulinosis cutis revealing Waldenström macroglobulinemia]
    E Riviere
    INSERM U897, service de médecine interne et tropicale, Hôpital Saint André, CHU de Bordeaux, université Bordeaux 2 Victor Segalen, 1, rue Jean Burguet, 33000 Bordeaux, France
    Rev Med Interne 32:e18-20. 2011
    ..Physicians should be aware of these clinical manifestations to avoid diagnostic delay...
  30. ncbi request reprint Usefulness of combined nerve and muscle biopsy in the diagnosis of amyloid neuropathy--a study of 6 new cases
    C Vital
    Centre National de la Recherche Scientifique, Bordeaux Institute of Neurosciences, UMR 5227, Bordeaux, France
    Clin Neuropathol 29:59-64. 2010
    ..During these past 5 years, we studied the muscle and nerve biopsies from 6 patients which revealed amyloid deposits. There were 2 patients with an idiopathic polyneuropathy and 4 with monoclonal gammopathy (MG)...
  31. ncbi request reprint [Exophtalmia revealing a mantle cell lymphoma]
    S Ralandison
    Service de Medecine Interne, Hôpital Saint André, 1, rue Jean Burguet, 33076 Bordeaux Cedex, France
    Rev Med Interne 27:719-22. 2006
    ..CAS REPORT: We reported a dry syndrome seen in a 67 year-old patient. The first patological analysis of accessory salivary glands evoked a primary Gougerot-Sjögren syndrome. Secondary, he presented a mantle cell lymphoma...
  32. ncbi request reprint [Nephrocalcinosis: initial manifestation of primary Sjögren's syndrome]
    E Lazaro
    Service de médecine interne et des maladies tropicales, Hôpital Saint André, 1, rue Jean Burguet, 33075 Bordeaux, France
    Rev Med Interne 24:745-7. 2003
    ..Nephrocalcinosis is a rare complication of chronic tubulointerstitial nephritis observed in primary Sjögren's syndrome. It can precede subjective sicca symptoms...
  33. doi request reprint Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic)
    Charlotte Lewden
    INSERM, U897, Bordeaux, France
    J Acquir Immune Defic Syndr 48:590-8. 2008
    ..The multicenter national Mortalité 2005 survey aimed at describing the distribution of causes of death among HIV-infected adults in France in 2005 and its changes as compared with 2000...
  34. ncbi request reprint Hypereosinophilic syndrome - lymphocytic variant transforming into peripheral T-cell lymphoma with severe oral manifestations
    J M d'Elbée
    Department of Dentistry and Oral Health, University Hospital of Bordeaux, Bordeaux, France
    Oral Surg Oral Med Oral Pathol Oral Radiol 116:e185-90. 2013
    ..Although progression into peripheral T-cell lymphoma is documented as a rare complication of HES-L, severe oral extension of HES-L is described for the first time. ..
  35. ncbi request reprint Clinical presentation of Behçet's disease in internal medicine
    B Dianati
    Department of Internal Medicine, Saint Andre Hospital, University of Bordeax II, Bordeaux, France
    Adv Exp Med Biol 528:81-2. 2003
  36. doi request reprint [Non-fortuitous dynamin II mutation-related association: neutropenia and Charcot-Marie-Tooth disease]
    A Saint-Lézer
    Service de médecine interne et maladies tropicales, Hôpital Saint André, CHU de Bordeaux, 1, rue Jean Burguet, 33000 Bordeaux, France
    Rev Neurol (Paris) 168:367-70. 2012
    ..Associated manifestations may guide molecular study...
  37. pmc HLA-DR expression on lymphocyte subsets as a marker of disease activity in patients with systemic lupus erythematosus
    J F Viallard
    Clinique de Medecine Interne, Hopital Haut Leveque, Pessac, France
    Clin Exp Immunol 125:485-91. 2001
    ..A larger prospective study is needed to demonstrate the real efficacy of this marker in predicting an exacerbation in SLE patients...
  38. doi request reprint [Wegener's granulomatosis with anti-MPO c-ANCA revealed by uveitis]
    G L Gaundong Mbéthé
    Service de médecine interne et maladies tropicales, pôle médecine urgences, Hôpital Saint André, Universite Victor Segalen Bordeaux 2, 33075 Bordeaux cedex, France
    Rev Med Interne 31:e11-3. 2010
    ..We report a 58-year-old woman who developed an uveitis as the presenting manifestation of Wegener's granulomatosis who highlight the usefulness of internist and ophthalmologist collaboration...